Gilead Sciences
GILD
#94
Rank
โ‚น16.554 T
Marketcap
โ‚น13,335
Share price
-0.56%
Change (1 day)
37.63%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): โ‚น566.39

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is โ‚น602.10. In 2024 the company made an earnings per share (EPS) of โ‚น35.09 a decrease over its 2023 EPS that were of โ‚น420.17.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น566.391514.04%
2024โ‚น35.09-91.65%
2023โ‚น420.1723.98%
2022โ‚น338.91-25.86%
2021โ‚น457.114850%
2020โ‚น9.23-97.64%
2019โ‚น391.550.9%
2018โ‚น388.0718.71%
2017โ‚น326.90-64.88%
2016โ‚น930.85-18.45%
2015โ‚น1,14155.28%
2014โ‚น735.07296.02%
2013โ‚น185.6217.89%
2012โ‚น157.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,028 70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น125.59-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น220.88-63.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,126 253.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,323 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น1,015 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น412.79-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1,323 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น674.75 12.07%๐Ÿ‡บ๐Ÿ‡ธ USA